Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration

International Immunology

Volumn 10, Issue 4, 1998, Pages 405-412

  McKall Faienza, Kim J ^d   Kawai, Kazuhiro ^a   Kündig, Thomas M ^b   Odermatt, Bernhard ^b   Bachmann, Martin F ^d   Zakarian, Arsen ^d   Mak, Tak W ^c   Ohashi, Pamela S ^d  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c AMGEN INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes; Inflammation; T lymphocytes; Tumor necrosis factor

Indexed keywords

CD8 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; DIABETES MELLITUS; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ISLETS OF LANGERHANS; LYMPHOCYTES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; PROTEINS; RATS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 0031919595     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.4.405     Document Type: Article

References (37)

1. Brockhaus, M., Schoenfeld, H.-J., Schlaeger, E.-J., Hunziker, W., Lesslauer, W. and Loetscher, H. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl Acad. Sci. USA 87:3127.
2. Hohmann, H.-P., Remy, R., Brockhaus, M. and van Loon, A. P. G. M. 1989. Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J. Biol. Chem. 264:14927.
3. Tracey, K. J. and Cerami, A. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317.
4. Pober, J. S. and Cotran, R. S. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
5. Slowik, M. R., De Luca, L. G., Fiers, W. and Pober, J. S. 1993. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am. J. Pathol. 143:1724.
6. Mackay, F., Loetscher, H., Stueber, D., Gehr, G. and Lesslauer, W. 1993. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55, J. Exp. Med. 177:1277.
7. Higuchi, Y., Herrera, P., Muniesa, P., Huarte, J., Belin, D., Ohashi, P. S., Aichele, P., Orci, L., Vassalli, J. D. and Vassalli, P. 1992. Expression of a TNF-alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719.
8. Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H. and Flavell, R. A. 1996. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. J. Immunol. 150:4136.
9. Neumann, B., Machleidt, T., Lifka, A., Pfeffer, K., Vestweber, D., Mak, T. W., Holzmann, B. and Kronke, M. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.
10. Cooper, W. O., Fava, R. A., Gates, G. A., Cremer, M. A. and Townes, A. S. 1992. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin. Exp. Immunol. 89:244.
11. Santambrogio, L., Hochwald, G. M., Leu, C. H. and Thorbecke, G. J. 1993. Antagonistic effects of endogenous and exogenous TGF-b and TNF on auto-immune diseases in mice. Immunopharmacol. Immunotoxicol. 15:461.
12. Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M. and Palladino, M. A. 1992. Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl Acad. Sci. USA 89:7375.
13. Williams, R. O., Feldmann, M. and Maini, R. N. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89:9784.
14. Piguet, P. F., Grau, G. E., Loetscher, V. R., Gentz, R. and Lesslauer, W. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombination soluble TNF receptor. Immunology 77:510.
15. Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J. and Clark, R. B. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193.
16. Selmaj, K. W., Raine, C. S. and Cross, A. H. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:694.
17. Selmaj, K. W., Papierz, W., Glabinski, A. and Kohno, T. 1995. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:135.
18. Held, W., MacDonald, H. R., Weissman, I. L., Hess, M. W. and Mueller, C. 1990. Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl Acad. Sci. USA 87:2239.
19. Yang, X., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D. and McDevitt, H. O. 1994. Effect of tumor necrosis factor a on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995.
20. Jacob, C. O., Also, S., Michie, S. A., McDevitt, H. O. and Acha-Orbea, H. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-a and interleukin 1. Proc. Natl Acad. Sci. USA 87:968.
21. Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K., Sawai, T., Nobunaga, T., Ohteki, T., Kumagai, K. and Toyota, T 1989. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84:1345.
22. Satoh, J., Seino, H., Shintani, S., Tanaka, S., Ohteki, T., Masuda, T., Nobunaga, T. and Toyota, T. 1990. Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α. J. Immunol. 145:1395.
23. Ohashi, P. S., Oehen, S., Bürki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. and Hengartner, H. 1991. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
24. Pircher, H., Bürki, K., Lang, R., Hengartner, H. and Zinkernagel, R. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342:559.
25. Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M. and Mak, T. W. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:456.
26. Ohashi, P. S., Oehen, S., Aichele, P., Pircher, H., Odermatt, B., Herrera, P., Higuchi, Y., Buerki, K., Hengartner, H. and Zinkernagel, R. M. 1993. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and TNF-α. J. Immunol. 150:5185.
27. Karupiah, G., Coupar, B. E., Andrew, M. E., Boyle, D. B., Phillips, S. M., Mullbacher, A., Blanden, R. V. and Ramshaw, I. A. 1990. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 144:290.
28. Kündig, T. M., Pfeffer, K., Simard, J. J. L., Miranda, R., Kawai, K., Ramshaw, I. A., Mak, T. W. and Ohashi, P. S. 1998. In vivo antiviral activity of TNFα is mediated via TNF receptor p55. Submitted.
29. Wboley, P. H., Dutcher, J., Widmer, M. B. and Gillis, S. 1993. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J. Immunol. 151:6602.
30. Mori, L., Iselin, S., DeLibero, G. and Lesslauer, W. 1996. Attenution of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-lgG1-treated and TNFR1-deficient mice. J. Immunol. 157:3178.
31. Barten, D. M. and Ruddle, N. H. 1994. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:123.
32. Bachmaier, K., Pummerer, C., Kozieradzki, I., Timm, E., Pfeffer, K., Neu, N. and Penninger, J. M. 1996. The low molecular weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 95:655.
33. Chaplin, D. D. and Hogquist, K. A. 1992. Interactions between TNF and interleukin-1. In: Beutler, B. ed. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, p. 197. Raven Press, New York.
34. Akira, S., Hirano, T., Taga, T. and Kishimoto, T. 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL and TNF). FASEB J 4:2860.
35. May, M. J. and Ager, A. 1992. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by Interferon gamma, tumor necrosis factor-α and interleukin 1β. Eur. J. Immunol. 22:219.
36. Pober, J. S., Gimbrone, M, A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R. and Springer, T. A. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1893.
37. Bevilacqua, M. P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767.